| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $605.5M | +37.1% |
| Cost of Revenue | $242.7M | +35.2% |
| Gross Profit | $362.8M | +38.4% |
| R&D Expense | $69.1M | +23.4% |
| SG&A Expense | $185.2M | +9.8% |
| Operating Income | $108.6M | +189.6% |
| Pre-tax Income | $107.5M | +200.5% |
| Income Tax | -$82.8M | — |
| Net Income | $190.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $84.3M | -13.8% |
| Inventory | $48.9M | +5.0% |
| Current Assets | $637.8M | +28.3% |
| Total Assets | $1.07B | +32.9% |
| Current Liabilities | $89.3M | +49.1% |
| Total Liabilities | $595.3M | +3.4% |
| Stockholders' Equity | $473.1M | +107.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $192.8M | +295.1% |
| Capital Expenditures | $59.3M | -54.3% |
| Investing Cash Flow | -$59.3M | +54.2% |
| Financing Cash Flow | $16.9M | -26.3% |
| Free Cash Flow | $133.6M | +265.0% |
| +436.6% |
| EPS (Basic) | $5.60 | +423.4% |
| EPS (Diluted) | $4.87 | +382.2% |